These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5420239)

  • 1. Clofibrate, serum enzymes, and muscle pain.
    Smith AF; Macfie WG; Oliver MF
    Br Med J; 1970 Apr; 2(5701):86-8. PubMed ID: 5420239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clofibrate-induced muscle damage in patients with chronic renal failure.
    Pierides AM; Alvarez-Ude F; Kerr DN
    Lancet; 1975 Dec; 2(7948):1279-82. PubMed ID: 54800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clofibrate-induced myopathy in patients with diabetes insipidus.
    Matsukura S; Matsumoto J; Chihara K; Yoshimoto Y; Fujita T
    Endocrinol Jpn; 1980 Jun; 27(3):401-3. PubMed ID: 7439122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofibrate-induced acute muscular syndrome.
    Sekowski I; Samuel P
    Am J Cardiol; 1972 Oct; 30(5):572-4. PubMed ID: 5073673
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of Preclinical Liver and Skeletal Muscle Biomarkers Following Clofibrate Administration in Wistar Rats.
    Maliver P; Festag M; Bennecke M; Christen F; Bánfai B; Lenz B; Winter M
    Toxicol Pathol; 2017 Jun; 45(4):506-525. PubMed ID: 28485676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofibrate-induced myopathy in a patient with primary hypothyroidism.
    Hattori N; Shimatsu A; Murabe H; Nishimura M; Nakamura H; Imura H
    Jpn J Med; 1990; 29(5):545-7. PubMed ID: 2089182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clofibrate in biliary cirrhosis.
    Drug Ther Bull; 1970 Jan; 8(3):12. PubMed ID: 5417898
    [No Abstract]   [Full Text] [Related]  

  • 8. No muscle damage from clofibrate.
    Langer T; Levy RI
    N Engl J Med; 1969 Jan; 280(2):111. PubMed ID: 5782472
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical importance of clofibrate induced increase of creatine kinase catalytic activity concentration in serum.
    Schneider J
    J Clin Chem Clin Biochem; 1981 Aug; 19(8):539-40. PubMed ID: 7276838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No muscle damage from clofibrate.
    Vester JW; Sabeh G; Danowski TS
    N Engl J Med; 1969 Jan; 280(2):110-1. PubMed ID: 5782471
    [No Abstract]   [Full Text] [Related]  

  • 11. Creatinekinase in hyperlipoproteinemic patients treated with clofibrate.
    Schneider J; Mühlfellner G; Kaffarnik H
    Artery; 1980; 8(2):164-70. PubMed ID: 7458683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallbladder disease as a side effect of drugs influencing lipid metabolism. Experience in the Coronary Drug Project.
    Coronary Drug Project Research Group
    N Engl J Med; 1977 May; 296(21):1185-90. PubMed ID: 323705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians.
    Research Committee of the Scottish Society of Physicians
    Br Med J; 1971 Dec; 4(5790):775-84. PubMed ID: 4943606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens.
    Watermeyer GS; Mann JI; Truswell AS; Levy I
    S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
    Laurin J; Lindor KD; Crippin JS; Gossard A; Gores GJ; Ludwig J; Rakela J; McGill DB
    Hepatology; 1996 Jun; 23(6):1464-7. PubMed ID: 8675165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute muscular syndrome associated with administration of clofibrate.
    Langer T; Levy RI
    N Engl J Med; 1968 Oct; 279(16):856-8. PubMed ID: 5677720
    [No Abstract]   [Full Text] [Related]  

  • 17. Five-year trial of clofibrate in ischaemic heart disease.
    Dewar HA
    Br Heart J; 1971 Jan; 33(1):145. PubMed ID: 5541898
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative clinical therapeutic trial with two hypolipidemic drugs: lofibrate and nafenopin.
    Dujovne CA; Weiss P; Bianchine JR
    Clin Pharmacol Ther; 1971; 12(1):117-25. PubMed ID: 5099889
    [No Abstract]   [Full Text] [Related]  

  • 19. Clofibrate myopathy: a case report and a review of the literature.
    Rush P; Baron M; Kapusta M
    Semin Arthritis Rheum; 1986 Feb; 15(3):226-9. PubMed ID: 3515563
    [No Abstract]   [Full Text] [Related]  

  • 20. [Side-effects of Clobifrate].
    Schlierf G
    Dtsch Med Wochenschr; 1971 May; 96(22):969. PubMed ID: 5578600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.